← All companies

CBDL

CBD Life Sciences Inc.

CBDL OTC Medicinal Chemicals & Botanical Products EDGAR ↗

$0.00

-0.00 -50.00%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$0.00 – $0.00

Recent SEC filings

40 most recent

Other filings

QUALIF Jun 8, 2026

CORRESP Jun 4, 2026

UPLOAD May 21, 2026

1-A May 15, 2026

253G2 FORM 253G2 May 19, 2025

QUALIF Mar 19, 2025

CORRESP Mar 18, 2025

CORRESP Mar 17, 2025

UPLOAD Mar 17, 2025

1-A POS Mar 17, 2025

1-A POS Mar 6, 2025

1-U Item 9.1 Jan 22, 2025

253G2 Sep 19, 2024

QUALIF Sep 17, 2024

CORRESP Sep 16, 2024

CORRESP Sep 16, 2024

CORRESP Sep 6, 2024

1-A POS Sep 6, 2024

UPLOAD Sep 5, 2024

1-A POS Aug 19, 2024

253G1 Jun 24, 2024

QUALIF Jun 21, 2024

CORRESP Jun 18, 2024

1-A/A Jun 18, 2024

CORRESP Jun 17, 2024

UPLOAD Jun 17, 2024

CORRESP Jun 5, 2024

1-A/A Jun 5, 2024

UPLOAD May 29, 2024

1-A May 2, 2024

1-Z May 1, 2024

1-U Item 7; Item 9.1 Jan 8, 2024

253G1 FORM 253G1 Aug 29, 2022

QUALIF Aug 26, 2022

CORRESP Aug 24, 2022

UPLOAD Aug 22, 2022

1-A Aug 18, 2022

1-Z Aug 18, 2022

253G2 FORM 253(G)(2) Jan 25, 2022

253G2 PROSPECTUS SUPPLEMENT Sep 1, 2021